Greene v. Abbott Laboratories

137 Misc. 2d 424, 521 N.Y.S.2d 382, 1987 N.Y. Misc. LEXIS 2644
CourtNew York Supreme Court
DecidedNovember 6, 1987
StatusPublished
Cited by2 cases

This text of 137 Misc. 2d 424 (Greene v. Abbott Laboratories) is published on Counsel Stack Legal Research, covering New York Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Greene v. Abbott Laboratories, 137 Misc. 2d 424, 521 N.Y.S.2d 382, 1987 N.Y. Misc. LEXIS 2644 (N.Y. Super. Ct. 1987).

Opinion

OPINION OF THE COURT

Ira Gammerman, J.

Defendants (E. R. Squibb & Sons, Abbott Laboratories, Merck & Co., The Upjohn Company and Eli Lilly & Company) move pursuant to CPLR 3211 (a) (5) and/or 3212 for partial summary judgment dismissing plaintiffs wrongful death claims as barred by the Statute of Limitations.

Plaintiff, as administrator of the estate of his deceased daughter, Susan Greene, relies on the revival statute (L 1986, ch 682, § 4)

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Monte v. National Gypsum Company
921 F.2d 405 (Second Circuit, 1990)
Monte v. National Gypsum Co.
921 F.2d 405 (Second Circuit, 1990)

Cite This Page — Counsel Stack

Bluebook (online)
137 Misc. 2d 424, 521 N.Y.S.2d 382, 1987 N.Y. Misc. LEXIS 2644, Counsel Stack Legal Research, https://law.counselstack.com/opinion/greene-v-abbott-laboratories-nysupct-1987.